Anagnostis, Panagiotis

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 3.

Journal Article

Slopien, Radoslaw; Wender-Ozegowska, Ewa; Rogowicz-Frontczak, Anita; Meczekalski, Blazej; Zozulinska-Ziolkiewicz, Dorota; Jaremek, Jesse D; Cano, Antonio; Chedraui, Peter; Goulis, Dimitrios G; Lopes, Patrice; Mishra, Gita; Mueck, Alfred; Rees, Margaret; Senturk, Levent M; Simoncini, Tommaso; Stevenson, John C; Stute, Petra; Tuomikoski, Pauliina; Paschou, Stavroula A; Anagnostis, Panagiotis; ... (2018). Menopause and diabetes: EMAS clinical guide. Maturitas, 117, pp. 6-10. Elsevier 10.1016/j.maturitas.2018.08.009

Anagnostis, Panagiotis; Paschou, Stavroula A; Mintziori, Gesthimani; Ceausu, Iuliana; Depypere, Herman; Lambrinoudaki, Irene; Mueck, Alfred; Pérez-López, Faustino R; Rees, Margaret; Senturk, Levent M; Simoncini, Tommaso; Stevenson, John C; Stute, Petra; Trémollieres, Florence A; Goulis, Dimitrios G (2017). Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al. Maturitas, 102, pp. 76-77. Elsevier 10.1016/j.maturitas.2017.04.019

Anagnostis, Panagiotis; Paschou, Stavroula A; Mintziori, Gesthimani; Ceausu, Iuliana; Depypere, Herman; Lambrinoudaki, Irene; Mueck, Alfred; Pérez-López, Faustino R; Rees, Margaret; Senturk, Levent M; Simoncini, Tommaso; Stevenson, John C; Stute, Petra; Trémollieres, Florence A; Goulis, Dimitrios G (2017). Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement. Maturitas, 101, pp. 23-30. Elsevier 10.1016/j.maturitas.2017.04.008

This list was generated on Wed Oct 16 01:23:03 2019 CEST.
Provide Feedback